Exscientia Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Exscientia has a total shareholder equity of £296.0M and total debt of £299.0K, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are £437.8M and £141.7M respectively.
Belangrijke informatie
0.1%
Verhouding schuld/eigen vermogen
UK£299.00k
Schuld
Rente dekkingsratio | n/a |
Contant | UK£292.78m |
Aandelen | UK£296.04m |
Totaal verplichtingen | UK£141.74m |
Totaal activa | UK£437.78m |
Recente financiële gezondheidsupdates
Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation
Jul 17Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Recent updates
Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others
Aug 08Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation
Jul 17Exscientia: Too Much Pessimism
Jun 10Exscientia: Drug Discovery Platform Attracting Partners And Cash
May 22Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Feb 26Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 12New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)
Aug 31We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher
Jul 21Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts
Aug 31Exscientia: Using AI To Power Drug Development
Aug 15Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline
Apr 12Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts
Jan 09Analyse van de financiële positie
Kortlopende schulden: EXAI's short term assets (£340.2M) exceed its short term liabilities (£57.4M).
Langlopende schulden: EXAI's short term assets (£340.2M) exceed its long term liabilities (£84.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: EXAI has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if EXAI's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: EXAI has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: EXAI has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 60.3% each year.